Skip to main content
. 2005 Oct 17;146(8):1069–1081. doi: 10.1038/sj.bjp.0706425

Table 4.

Competition-binding parameters of BODIPY®-labelled and native peptides of the NPY family in various NPY Y5-like receptor assays

  Y5 HEK293-transfected cells Rat brain
Competitors Ki (nM) Ki (nM)
NPY 1.3±0.4 (3)a 4.0±1.9 (5)
BODIPY®TMR-NPY 2.0±0.8 (3) 2.9±1.5 (4)
[Leu31, Pro34]NPY 5.2±0.3 (3) 7.7±2.8 (5)
BODIPY®TMR-[Leu31, Pro34]NPY 1.3±0.4 (3)* 2.7±0.3 (4)
[Leu31, Pro34]PYY 3.2±0.8 (3) 3.5±0.9 (5)
BODIPY®FL-[Leu31, Pro34]PYY 3.0±0.7 (3) 4.0±1.0 (4)
PYY(3–36) 25±6 (3) 14±2 (5)
BODIPY®FL-PYY(3–36) 30±5 (3) 12.0±1.0 (4)
hPP 1.6±0.4 (3) 2.0±0.7 (5)
BODIPY®FL-hPP 15±3 (3)* 26±10 (4)*
[hPP(1–17), Ala31, Aib32]NPY 0.6±0.2 (3) 0.7±0.2 (5)
BODIPY®TMR-[hPP(1–17), Ala31, Aib32]NPY 0.4±0.1 (3) 0.6±0.1 (4)
[cPP(1–7), NPY(19–23), Ala31, Aib32, Gln34]hPP 0.1±0.04 (3) 0.15±0.03 (5)
BODIPY®TMR-[cPP(1–7), NPY(19–23), Ala31, Aib32, Gln34]hPP 0.1±0.03 (3) 0.2±0.1 (4)

Data are the mean±s.e.m. of three to five determinations, each performed in triplicate.

a

Number in parenthesis represents the number of determinations. Ki represents the concentration of competitor needed to inhibit 50% specifically bound [125I][Leu31, Pro34]PYY in the presence of BIBO3304 in order to mask Y1 receptors.

*

P<0.05, fluorescent vs nonfluorescent peptide.